'AstraZeneca disappoints us': Pfizer
The Local/at - [email protected]
Published: 6 May, 2014 CET.
Updated: Tue 6 May 2014 08:55 CET
US drugs giant Pfizer has said it was disappointed with Anglo-Swedish pharmaceuticals company AstraZeneca for not only rejecting its takeover bid, but refusing to discuss alternatives.
"Any option you can think of would be an option," Pfizer CFO Frank D'Amelio told the Reuters news agency.
He said he had met with a small number of AstraZeneca heads in London, host to the company's headquarters, and said that Pfizer's offer of £50 a share was "compelling". Reuters reported, however, that analysts thought Pfizer might have to go up to £52 to £55 pounds to get the Anglo-Swedes to bite.
D'Amelio, who said Pfizer was very disappointed at the unwillingness to enter into talks, said he did not rule out a hostile takeover bid on AstraZeneca.
Comments
See Also
"Any option you can think of would be an option," Pfizer CFO Frank D'Amelio told the Reuters news agency.
He said he had met with a small number of AstraZeneca heads in London, host to the company's headquarters, and said that Pfizer's offer of £50 a share was "compelling". Reuters reported, however, that analysts thought Pfizer might have to go up to £52 to £55 pounds to get the Anglo-Swedes to bite.
D'Amelio, who said Pfizer was very disappointed at the unwillingness to enter into talks, said he did not rule out a hostile takeover bid on AstraZeneca.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.